Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Thymidylate Synthase
100%
Anticancer Agents
100%
Thymidylate Synthase Inhibitors
100%
Bench to Bedside
100%
Inhibitor Compound
42%
5′-monophosphate
28%
5-fluorouracil (5-FU)
28%
Drug Resistance
28%
Deoxythymidine
28%
Novel Mechanism
28%
Cellular Drugs
28%
In Cancer
14%
Cancer Chemotherapy
14%
Cancer Cells
14%
Clinical Efficacy
14%
Folate
14%
Antifolate
14%
Potent Inhibitor
14%
5-bisphosphate
14%
Antineoplastic Agents
14%
Human Malignancies
14%
Pemetrexed
14%
Nucleoside Analogues
14%
Raltitrexed
14%
First-in-class
14%
Reductive Methylation
14%
Folate Enzymes
14%
Resistance Mechanism
14%
Future Success
14%
Novel Combination Therapy
14%
Nolatrexed
14%
2′-deoxyuridine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Thymidylate Synthase
100%
Anticarcinogen
100%
Thymidylate Synthase Inhibitor
100%
Fluorouracil
28%
Folic Acid
28%
Drug Resistance
28%
Thymidine
28%
Malignant Neoplasm
14%
Combination Therapy
14%
Cancer Chemotherapy
14%
Folic Acid Antagonist
14%
Deoxyuridine
14%
Pemetrexed
14%
Enzymes
14%
Raltitrexed
14%
Plevitrexed
14%
Nolatrexed
14%